NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Aditya Birla Capital Delivers Robust Performance in Lending Businesses

Aditya Birla Capital, a leading financial services company, has reported a robust performance in its lending businesses for the quarter ended March 2026. The company's Non-Banking Financial Company (NBFC) and Housing Finance Company (HFC) businesses delivered a Return on Assets (RoA) of 2.3% and 2.1%, respectively, in the fourth quarter of fiscal year 2026. This performance is a testament to the company's strong execution and ability to drive industry-leading growth and cost efficiencies.

Key Highlights

Business SegmentQ4 FY26 RoAFY27E Target RoAFY26-28E Growth CAGR
NBFC2.3%~2.5%-
HFC2.1%->30%

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The company's HFC business continues to lead the industry in terms of growth, with stable asset quality metrics. With the recent deal with Advent, growth capital is expected to flow into the HFC business, positioning it well to sustain its growth momentum over the next two fiscal years. We believe that the HFC business can achieve a compound annual growth rate (CAGR) of over 30% between fiscal years 2026 and 2028.

Outlook and Recommendation

Given the robust performance in the lending businesses and a steady outlook, we retain our BUY recommendation for Aditya Birla Capital. Our revised Sum of the Parts (SoTP)-based target price for the company is INR 420, up from INR 400 earlier. We believe that the company's strong execution and growth potential make it an attractive investment opportunity for investors.

Investor Takeaway

Investors should consider buying Aditya Birla Capital due to its strong execution and growth prospects.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.